February 2026 Content Release Notes Copied
Problem Groups
Updates
The Problems > Add Details area is updated with applicable documentation points for the following diagnoses.
Curbside Connect with Dr. Truong for Melanoma Patient is no longer available for Melanoma, Skin.
Lab Analytes & Panels
Summary
February’s updates focused on expanding hereditary cancer testing (BRCA, Lynch, multi-cancer, and comprehensive panels), along with significant growth in molecular oncology reporting through Tempus. Additions also included pharmacogenomics (DPYD, UGT1A1), infectious disease panels, specialty chemistry tests, and oncology rebase line tumor markers, strengthening precision diagnostics and treatment monitoring.
Additions
- Empower BRCA1 & BRCA2 panel
- Empower BRCA1 & BRCA2 and breast STAT (10 genes total) + comprehensive (81) panel
- Empower BRCA1 & BRCA2 and multi-cancer (40) panel
- Empower BRCA1 & BRCA2 and comprehensive (81) panel
- Empower lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) panel
- Empower lynch syndrome and multi-cancer (40) panel
- Empower lynch syndrome and comprehensive (81) panel
- Empower custom (Please enter custom ID only) panel
- Legionella and strep pneumoniae antigens, urine panel
- Legionella and strep pneumoniae antigens, urine
- Antibody identification, JKA panel
- Elution, JKA panel
- AA O2 gradient, mm Hg
- Chromium and Cobalt panel
- Iodine, random urine panel
- Donor Cytomegalovirus (CMV) Ab, IgG panel
- Porphyrins, total serum panel
- Pneumococcal antibody panel (14 Serotype)
- HLA DQB1 high res panel
- Giardia Lamblia Ag, EIA panel
- Uncorrected WBC count, x10^3/uL
- HDV Antibody, IgG/IgM
- Hepatitis D virus (HDV) antibody, IgG and IgM panel
- % CD20-B Cells
- EER dihydropyrimidine dehydrogenase note
- DPYD phenotype
- DPYD allele 2
- DPYD allele 1
- DPYD specimen
- Tempus PD-L1 SP142 report panel
- Tempus PD-L1 SP142 amendment report panel
- Tempus PD-L1 SP142 addendum report panel
- Tempus PD-L1 SP263 report panel
- Tempus PD-L1 SP263 amendment report panel
- Tempus PD-L1 SP263 addendum report panel
- Tempus MMR report panel
- Tempus MMR amendment report panel
- Tempus MMR addendum report panel
- Tempus claudin18 IHC FDA neogenomics report panel
- Tempus claudin18 IHC FDA neogenomics amendment report panel
- Tempus claudin18 IHC FDA neogenomics addendum report panel
- Tempus CMET FDA neogenomics report panel
- Tempus CMET FDA neogenomics amendment report panel
- Tempus CMET FDA neogenomics addendum report panel
- Tempus PTEN report panel
- Tempus PTEN amendment report panel
- Tempus PTEN addendum report panel
- Tempus PURIST report panel
- Tempus PURIST amendment report panel
- Tempus PURIST addendum report panel
- Tempus DPYD report panel
- Tempus DPYD amendment report panel
- Tempus DPYD addendum report panel
- Tempus HRD report panel
- Tempus HRD amendment report panel
- Tempus HRD addendum report panel
- Tempus TO report panel
- Tempus TO amendment report panel
- Tempus TO addendum report panel
- Tempus immune profile score report panel
- Tempus immune profile score amendment report panel
- Tempus immune profile score addendum report panel
- Tempus UGT1A1 report panel
- Tempus UGT1A1 amendment report panel
- Tempus UGT1A1 addendum report panel
- Tempus 1p19q FISH report panel
- Tempus 1p19q FISH amendment report panel
- Tempus 1p19q FISH addendum report panel
- Tempus MGMT methylation report panel
- Tempus MGMT methylation amendment report panel
- Tempus MGMT methylation addendum report panel
- Tempus report summary report panel
- Tempus report summary amendment report panel
- Tempus report summary addendum report panel
- Tempus XR report panel
- Tempus XR amendment report panel
- Tempus XR addendum report panel
- Tempus XE report panel
- Tempus XE amendment report panel
- Tempus XE addendum report panel
- Tempus XF report panel
- Tempus XF amendment report panel
- Tempus XF addendum report panel
- Tempus familial variant testing report panel
- Tempus familial variant testing amendment report panel
- Tempus familial variant testing addendum report panel
- Tempus XG report panel
- Tempus XG amendment report panel
- Tempus XG addendum report panel
- Tempus CancerNext report panel
- Tempus CancerNext amendment report panel
- Tempus CancerNext addendum report panel
- Tempus PLUS CancerNext expanded report panel
- Tempus PLUS CancerNext expanded amendment report panel
- Tempus PLUS CancerNext expanded addendum report panel
- Tempus CancerNext + RNAinsight report panel
- Tempus CancerNext + RNAinsight amendment report panel
- Tempus CancerNext + RNAinsight addendum report panel
- Tempus CancerNext expanded + RNAinsight report panel
- Tempus CancerNext expanded + RNAinsight amendment report panel
- Tempus CancerNext expanded + RNAinsight addendum report panel
- Tempus XM report panel
- Tempus XM amendment report panel
- Tempus XM addendum report panel
- Tempus XT report panel
- Tempus XT amendment report panel
- Tempus XT addendum report panel
- Tempus XT CDX report panel
- Tempus XT CDX amendment report panel
- Tempus XT CDX addendum report panel
- Tempus HER2 IHC report panel
- Tempus HER2 IHC amendment report panel
- Tempus HER2 IHC addendum report panel
- Tempus HER2 FISH report panel
- Tempus HER2 FISH amendment report panel
- Tempus HER2 FISH addendum report panel
- Tempus FOLR1 IHC report panel
- Tempus FOLR1 IHC amendment report panel
- Tempus FOLR1 IHC addendum report panel
- Tempus PD-L1 22C3 report panel
- Tempus PD-L1 22C3 amendment report panel
- Tempus PD-L1 22C3 addendum report panel
- Tempus PD-L1 28-8 report panel
- Tempus PD-L1 28-8 amendment report panel
- Tempus PD-L1 28-8 addendum report panel
- Solid tumor profile panel
- Liquid biopsy NGS profile panel
- Heme DNA profile panel
- Heme RNA profile panel
- Heme plus panel
- CEA rebaseline, ng/mL
- CA 15-3 rebaseline, U/mL
- CA 19-9 rebaseline, U/mL
- CA 125 rebaseline U/mL
- PSA rebaseline, U/mL
- HER2 (other) IHC panel
Medications
Additions
- CR-001 invest IV
- Dexcom G6
- Dexcom G7
- DFMO invest Oral
- Freestyle Libre 2
- Freestyle Libre 3
- Nifedipine-Lidocaine Cream 0.5 %-5 %
- Paltusotine invest Oral
- Pumitamig or Nivolumab invest IV
- QXL138AM invest IV
- YL211 invest IV
Updates
| Medications | Updates |
| Amivantamab-rHuPH20 invest (JNJ-61186372-rHuPH20 invest Subcutaneous) | Removed General Instructions:
|
| AMXT 1501 invest Oral | Category changed from Antineoplastic to:
New Form available:
New SIGs available:
|
| GSK5764227 invest IV | Category changed from Antineoplastic to:
New SIGs available:
|
| KITE-753 invest IV | Category changed from Antineoplastic to:
New SIGs available:
|
| Volrustomig invest (MEDI5752 invest IV) | Category changed from Antineoplastic to:
New SIGs available:
|
Regimen Library
Additions
| Regimen Name | Diagnosis |
| Amivantamab SQ + Pemetrexed + Carboplatin Q21D fb Amivantamab SQ + Pemetrexed Q21D Maintenance (Weight greater than or equal to 80 kg) | Lung Cancer, Non-small Cell (NSCLC) |
| Amivantamab SQ + Pemetrexed + Carboplatin Q21D fb Amivantamab SQ + Pemetrexed Q21D Maintenance (Weight less than 80 kg) | Lung Cancer, Non-small Cell (NSCLC) |
| Amivantamab SQ C1-2 D1,8 fb C3+ D1 Q14D | Lung Cancer, Non-small Cell (NSCLC) |
| Daratumumab IV + Lenalidomide + Bortezomib D1,4,8,11 + Dexamethasone (RVD) Q21D (Non-Transplant Candidates) (Part 1 of 2) | Multiple Myeloma (MM) |
| Daratumumab IV + Lenalidomide + Bortezomib D1,4,8,11 + Dexamethasone (RVD) Q21D (Non-Transplant Candidates) (Part 1 of 2: C1 Split Dosing) | Multiple Myeloma (MM) |
| Daratumumab IV + Lenalidomide + Dexamethasone Q28D Maintenance (Non-Transplant Candidates) (Part 2 of 2) | Multiple Myeloma (MM) |
| Fam-trastuzumab Deruxtecan-nxki (Enhertu) + Pertuzumab IV Q21D | Breast Cancer |
| Lazertinib + Amivantamab SQ C1 D1,8,15,22 fb C2+ D1,15 Q28D | Lung Cancer, Non-small Cell (NSCLC) |
| Mosunetuzumab-axgb SQ (Lunsumio Velo) D1,8,15 fb D1 Q21D | Lymphoma, Non-Hodgkin (NHL) (Parent) |
| Pembrolizumab SQ + Paclitaxel (Weekly) + Carboplatin (Q3W) Q42D fb Pembrolizumab SQ + AC (Dose Dense) Q42D | Breast Cancer |
| Polatuzumab Vedotin D1 + Mosunetuzumab-axgb SQ (Lunsumio Velo) D1,8,15 fb D1 Q21D | Lymphoma, Non-Hodgkin (NHL) (Parent) |
| Sacituzumab govitecan (Trodelvy) D1,8 + Pembrolizumab SQ Q21D | Breast Cancer |
| Sacituzumab govitecan (Trodelvy) D1,8 + Pembrolizumab Q21D | Breast Cancer |
| Sevabertinib Q30D | Lung Cancer, Non-small Cell (NSCLC) |
| Teclistamab-cqyv (Tecvayli) SQ + Daratumumab SQ D1,8,15,22 fb D1,15 fb D1 Q28D | Multiple Myeloma (MM) |
Updates
Regimens for the following diagnoses have been updated based on the Collaborative Care Committee voting. Changes include but are not limited to reference updates, drug infusion instruction updates, renaming regimens, premedication template updates, and number of cycles.
- All Problems
- Arthritis, Rheumatoid
- Breast Cancer
- Leukemia, Acute Lymphocytic (ALL)
- Leukemia, Chronic Myeloid (CML)
- Lung Cancer, Small Cell (SCLC)
- Lymphoma, Non-Hodgkin (NHL) (Parent)
- Melanoma, Mucosal, Head and Neck
- Melanoma, Skin
- Melanoma, Uvea, Ciliary Body/Choroid
- Melanoma, Uvea, Iris
- Multiple Myeloma (MM)
Renames
| Previous Name | New Name |
| Blinatumomab D1-28 Q42D (ALL MRD Positive, 24 hr bag change) | Blinatumomab D1-28 Q42D (ALL Consolidation or MRD Positive, 24 hr bag change) |
| Blinatumomab D1-28 Q42D (ALL MRD Positive, 7-day bag change) | Blinatumomab D1-28 Q42D (ALL Consolidation or MRD Positive, 7-day bag change) |
| Mosunetuzumab-axgb (Lunsumio) D1,8,15 fb D1 Q21D | Mosunetuzumab IV (Lunsumio) D1,8,15 fb D1 Q21D |
| Pembrolizumab (Flat Dose) + Paclitaxel D1,8,15,22,29,36 + Carboplatin D1,22 Q42D fb Pembrolizumab (Flat Dose) + Doxorubicin + Cyclophosphamide (AC) D1,15,29 Q42D Dose Dense | Pembrolizumab + Paclitaxel (Weekly) + Carboplatin (Q3W) Q42D fb Pembrolizumab + AC (Dose Dense) Q42D |
Removals
| Regimen Name | Diagnosis |
| Eflornithine Q30D | Brain Tumor (Parent), Neuroblastoma |
Billing & HCPCS Codes
Additions
| Medication | HCPCS Codes |
| amivantamab-hyaluronidase-lpuj Subcutaneous | J9999 per 2240 mg |
| Denosumab-qbde Subcutaneous (60 mg/mL – Enoby) | J3590 per 60 mg |
| Denosumab-qbde Subcutaneous (120 mg/1.7 mL – Xtrenbo) | J3590 per 120 mg |
| furosemide Subcutaneous (Lasix ONYU) | J3490 per 80 mg |
| mosunetuzumab-axgb Subcutaneous | J9350 per 1 mg |
| narsoplimab-wuug IV | J3590 per 370 mg |
| nivolumab-hyaluronidase-nvhy Subcutaneous | J9289 per 2 mg |
| Octreotide Subcutaneous Pen Injector | J3490 per 2500 mcg |
| Zinc Chloride IV | J3490 per 10 mg |
Problems (SNOMED)
Removals
The standard body has retired the following concepts. Where applicable, a replacement concept has been provided:
| Retired SNOMED Concept ID Description | Replaced by Description |
| 3-alpha-allo-tetrahydrocortisol | N/A |
| 5-trimethoxyamphetamine | N/A |
| Ability to transfer between wheelchair and toilet | N/A |
| Able to transfer between wheelchair and toilet | N/A |
| Abnormal biochemistry finding | N/A |
| Abnormal cardiac laboratory result | N/A |
| Abnormal cytologic finding in specimen from digestive organ and abdominal cavity | N/A |
| Abnormal cytological finding in specimen from respiratory organ and thorax | N/A |
| Abnormal fetal duplication | N/A |
| Abnormal finding on cytological and histological examination of urine | N/A |
| Abnormal histological finding in specimen from digestive organ and abdominal cavity | N/A |
| Abnormal histological finding in specimen from respiratory organ and thorax | N/A |
| Abnormal immunological finding in specimen from digestive organ and abdominal cavity | N/A |
| Abnormal immunological finding in specimen from respiratory organ and thorax | N/A |
| Abnormal immunology finding | N/A |
| Abnormal microbiological finding in specimen from digestive organ and abdominal cavity | N/A |
| Abnormal microbiological finding in specimen from respiratory organ and thorax | N/A |
| Abnormal microbiology finding | N/A |
| Accidental alternative medicine overdose | N/A |
| Accidental alternative medicine poisoning | N/A |
| Accidental cut, puncture, perforation or hemorrhage during abdominal paracentesis | N/A |
| Accidental cut, puncture, perforation or hemorrhage during administration of enema | N/A |
| Accidental cut, puncture, perforation or hemorrhage during aspirating needle biopsy | N/A |
| Accidental cut, puncture, perforation or hemorrhage during aspiration of fluid or tissue, puncture and catheterization | N/A |
| Accidental cut, puncture, perforation or hemorrhage during blood sampling | N/A |
| Accidental cut, puncture, perforation or hemorrhage during endoscopic examination | N/A |
| Accidental cut, puncture, perforation or hemorrhage during heart catheterization | N/A |
| Accidental cut, puncture, perforation or hemorrhage during infusion | N/A |
| Accidental cut, puncture, perforation or hemorrhage during infusion or transfusion | N/A |
| Accidental cut, puncture, perforation or hemorrhage during injection | N/A |
| Accidental cut, puncture, perforation or hemorrhage during injection or vaccination | N/A |
| Accidental cut, puncture, perforation or hemorrhage during kidney dialysis | N/A |
| Accidental cut, puncture, perforation or hemorrhage during lumbar puncture | N/A |
| Accidental cut, puncture, perforation or hemorrhage during medical care | N/A |
| Accidental cut, puncture, perforation or hemorrhage during surgical operation | N/A |
| Accidental cut, puncture, perforation or hemorrhage during thoracentesis | N/A |
| Accidental cut, puncture, perforation or hemorrhage during transfusion | N/A |
| Accidental cut, puncture, perforation or hemorrhage during vaccination | N/A |
| Accidental wound during transfusion | N/A |
| Acetobacter hansenii | Komagataeibacter hansenii |
| Acquired disease | N/A |
| Acquired phlebectasia | N/A |
| Acrania | N/A |
| Actinobacteridae | N/A |
| Actinomadura glomerata | Actinocorallia glomerata |
| Actinomadura libanotica | Actinocorallia libanotica |
| Actinomadura longicatena | Actinocorallia longicatena |
| Actinomadura pyogenes | N/A |
| Actinomyces ericksonii | N/A |
| Actinopolyspora iraqiensis | Saccharomonospora iraqiensis |
| Active tuberculosis | N/A |
| Activities, functions and processes | N/A |
| Acute angle-closure glaucoma | Acute angle closure |
| Acute angle-closure glaucoma of left eye | Acute angle closure of left eye |
| Acute angle-closure glaucoma of right eye | Acute angle closure of right eye |
| Acute cervical lymphadenitis | N/A |
| Acute diffuse tuberculosis | N/A |
| Acute disease of hematopoietic system | N/A |
| Acute fibrinous bronchitis | Plastic bronchitis |
| Acute left-sided heart failure | N/A |
| Acute lymphadenitis of neck | N/A |
| Acute seizure due to infection of central nervous system | Acute symptomatic epileptic seizure due to acute infection of central nervous system |
| Additional pain and sensation observations | N/A |
| Adjustment of suture within Baerveldt tube | N/A |
| Adjustment of suture within Molteno tube | N/A |
| Administration | N/A |
| Administration of treatment via specific route | N/A |
| Administrative / management procedure | N/A |
| Advanced collapse of scapholunate joint due to osteoarthritis | Osteoarthritis of wrist joint due to SLAC (scapholunate advanced collapse) of wrist |
| Adverse cutaneous reaction to alternative medical therapy | N/A |
| Adverse reaction to bases and inactive substances | N/A |
| Adverse reaction to emollients, demulcents and protectants | N/A |
| Adverse reaction to local astringents and local detergents | N/A |
| Adverse reaction to mixed bacterial vaccines, excluding combinations with a pertussis component | N/A |
| Adverse reaction to mixed viral-rickettsial and bacterial vaccines except combinations with a pertussis component | N/A |
| Adverse reaction to premedication | N/A |
| Aerococcus sanguicola | Aerococcus sanguinicola |
| Aeromonas canina | N/A |
| Afterimage | N/A |
| Air contrast barium enema | N/A |
| Air contrast swallow | N/A |
| Alcaligenes rhulandii | Achromobacter ruhlandii |
| Alcohol withdrawal-induced convulsion | Acute symptomatic epileptic seizure due to alcohol withdrawal |
| Alcohol-related fit | N/A |
| Allergy to bases and inactive substances | N/A |
| Allo-tetrahydrocortisol measurement | N/A |
| Alternative arterial hierarchy | N/A |
| Alternative medicine agent | N/A |
| Alternative medicine overdose | N/A |
| Alternative medicine overdose of undetermined intent | N/A |
| Alternative medicine poisoning | N/A |
| Alternative medicine poisoning of undetermined intent | N/A |
| Alternative medicines | N/A |
| Alternative medicines adverse reaction | N/A |
| Alternative medicines allergy | N/A |
| Alveolar pyorrhea | Pyorrhea |
| Amphixenosis | N/A |
| Amphotericin B phospholipid complex | N/A |
| Amphotericin B phospholipid complex only product | N/A |
| Amphotericin B phospholipid complex only product in parenteral dose form | N/A |
| Ampule – unit of product usage | N/A |
| Amycolatopsis orientalis ss orientalis | Amycolatopsis orientalis |
| Amycolatopsis rugosa | Prauserella rugosa |
| Anaerobaculum | Acetomicrobium |
| Anaerovibrio burkinabensis | Anaeroarcus burkinensis |
| Anaerovibrio glycerini | Anaerosinus glycerini |
| Anal spasm | N/A |
| Analgesics and non-steroidal anti-inflammatory drug allergy | N/A |
| Analgesics requested | Analgesic requested |
| Anastomosis main bile duct to duodenum | N/A |
| Anastomosis of colon to anal canal | N/A |
| Anatomic narrow angle glaucoma of left eye | Primary angle closure glaucoma of left eye |
| Anatomic narrow angle glaucoma of right eye | Primary angle closure glaucoma of right eye |
| Anatomical narrow angle glaucoma | Primary angle-closure glaucoma |
| Anatomical narrow angle glaucoma with borderline intraocular pressure | N/A |
| Anesthesia type | N/A |
| Animal transmitted infectious disease | N/A |
| Ankylosis or instability of cervical, thoracic or lumbar spine | N/A |
| Anomalies of cerebellum | N/A |
| Anoxic epileptic seizure | Acute symptomatic epileptic seizure due to hypoxia |
| Antenatal blood group screening status | N/A |
| Antenatal HIV blood screening test requested | Antenatal HIV screening requested |
| Antenatal sickle cell screening categorized by action status | N/A |
| Antenatal syphilis screening categorized by action status | N/A |
| Antenatal thalassemia blood screening test requested | Antenatal thalassemia screening requested |
| Anthroposophical agent | N/A |
| Anthroposophical medicine | N/A |
| Anthroposophical medicine adverse reaction | N/A |
| Anthroposophical medicine allergy | N/A |
| Anthroposophical medicine regime | N/A |
| Anthropozoonosis | N/A |
| Antineoplastic/immunosuppressant/immunostim adverse reaction | N/A |
| Antineoplastic/immunosuppressant/immunostimulant allergy | N/A |
| Antineoplastic/immunosuppressant/immunostimulant overdose | N/A |
| Antineoplastic/immunosuppressant/immunostimulant poisoning | N/A |
| Anxiety disorder of childhood OR adolescence | N/A |
| Applicator – unit of product usage | N/A |
| Aquagenic epilepsy | N/A |
| Arbovirus | N/A |
| Arthritis of multiple sites following helminthiasis | Arthritis following helminthiasis |
| Arthritis secondary to hematological malignancy | Arthritis due to hematological malignancy |
| Arthritis secondary to malignancy | Arthritis due to malignant neoplastic disease |
| Arthritis secondary to non-hematological malignancy | Arthritis due to malignant neoplastic disease |
| Arthrocentesis and injection of intermediate joint | N/A |
| Arthrocentesis of intermediate joint | N/A |
| Arthroderma grubyi | Lophophyton gallinae |
| Arthroderma otae | Microsporum canis |
| Arthroderma vanbreuseghemii | Trichophyton mentagrophytes |
| Arthropathies and related disorders | N/A |
| Arthropathy associated with mycoses, of multiple sites | Arthropathy associated with a mycosis |
| Arthropod-borne infectious disease | N/A |
| Arthropod-borne organism | N/A |
| Arthropod-borne viral encephalitis, vector unknown | N/A |
| Aspergillus maydis | N/A |
| Aspergillus notatum | N/A |
| Aspergillus phialiseptus | Aspergillus fumigatus |
| Aspergillus taumanii | N/A |
| Aspiration of ectopic pregnancy from cornu of fallopian tube | Aspiration of ectopic interstitial uterine pregnancy |
| Aspiration of liquor or mucus in newborn | N/A |
| Aspirin exacerbated respiratory disease | Non-steroidal anti-inflammatory drug exacerbated respiratory disease |
| Aspirin-induced asthma | Non-steroidal anti-inflammatory drug exacerbated respiratory disease |
| Assessment scales Aa-Az | N/A |
| Assessment scales Ba-Bz | N/A |
| Assessment scales Ca-De | N/A |
| Assessment scales Di-Ga | N/A |
| Assessment scales Ge-Iz | N/A |
| Assessment scales Ja-Me | N/A |
| Assessment scales Mi-Oz | N/A |
| Assessment scales Pa-Ra | N/A |
| Assessment scales Re-Sc | N/A |
| Assessment scales Se-Su | N/A |
| Assessment scales Sw-Va | N/A |
| Assessment scales Ve-Zu | N/A |
| Attachment promotion | N/A |
| Attention to enteral tube | N/A |
| Atypical mycobacteria species a-m | N/A |
| Atypical mycobacteria species n-z | N/A |
| Audiant bone conductor | Anchored bone-conduction hearing aid |
| Auditory appliance | N/A |
| Avian schistosome | N/A |
| Avoidant disorder of childhood OR adolescence | N/A |
| Awaiting housing improvement | N/A |
| Baby premature 24-26 weeks | N/A |
| Baby premature 26-28 weeks | N/A |
| Baby premature 28-32 weeks | N/A |
| Baby premature 32-36 weeks | N/A |
| Bacillus arsenicus | N/A |
| Bacillus dipsosauri | Gracilibacillus dipsosauri |
| Bacillus ehimensis | Paenibacillus ehimensis |
| Bacillus halodenitrificans | Virgibacillus halodenitrificans |
| Bacillus kaustophilus | Geobacillus kaustophilus |
| Bacillus methylotrophicus | Bacillus velezensis |
| Bacillus psychrophilus | Sporosarcina psychrophila |
| Bacillus pulvifaciens | Paenibacillus larvae |
| Bacillus salexigens | Virgibacillus salexigens |
| Bacillus thermocatenulatus | Geobacillus thermocatenulatus |
| Bag – unit of product usage | N/A |
| Bar – unit of product usage | N/A |
| Barium coated food gastric transit study | N/A |
| Barium enema for radiological reduction of intussusception of ileum | Fluoroscopy guided reduction of intussusception of ileum with barium enema |
| Barium small bowel meal | N/A |
| Barrier preparation adverse reaction | N/A |
| Barrier preparation allergy | N/A |
| Base – unit of product usage | N/A |
| Bathing patient in isolette | N/A |
| Bdellovibrio stolpii | Bacteriovorax stolpii |
| Behavior assessment | N/A |
| Benign breast condition | N/A |
| Benign mesothelioma of pericardium | N/A |
| Benign neoplasm of perinephric tissue | N/A |
| Benign tumor of mesothelial and soft tissue | N/A |
| Benign tumor of oral cavity, lips, salivary glands | N/A |
| Beta-lipotrophic hormone | N/A |
| Beta-N-acetylhexosaminidase A | N/A |
| Beta-N-acetylhexosaminidase B | N/A |
| Bifid tongue | N/A |
| Bifidobacterium denticolens | Parascardovia denticolens |
| Bifidobacterium infantis | N/A |
| Bifidobacterium inopinatum | Scardovia inopinata |
| Bifidobacterium lactis | Bifidobacterium animalis subspecies lactis |
| Bifidobacterium ruminatium | Bifidobacterium ruminantium |
| Biguanide disinfectant | Biguanide antiseptic and/or disinfectant |
| Biguanide disinfectant adverse reaction | Biguanide antiseptic and/or disinfectant adverse reaction |
| Bilateral acute angle-closure glaucoma | Bilateral acute angle closure |
| Bilateral eye anatomic narrow angle glaucoma | Bilateral primary angle closure glaucoma |
| Bilateral metatarsus primus varus of feet | N/A |
| Bi-level positive airway pressure | N/A |
| Biochemistry interpretation | N/A |
| Birth trauma, asphyxia and hypoxia | N/A |
| Blastoschizomyces capitatus or Candida krusei or Prototheca zopfii | N/A |
| Bleeding from nasopharynx | N/A |
| Bleeding of pharynx | N/A |
| Blister – unit of product usage | N/A |
| Blister cell | N/A |
| Blood and tissue coccidia | N/A |
| Blood and tissue flagellate | N/A |
| Blood and tissue microsporidian | N/A |
| Blood and tissue protozoan | N/A |
| Blood procedure AND/OR transfusion | N/A |
| Blood product reservation, release, transfusion or disposition | N/A |
| Blood sporozoan | N/A |
| Blood trematode | N/A |
| Borderline biochemistry finding | N/A |
| Borderline hematology finding | N/A |
| Borderline histology finding | N/A |
| Borderline microbiology finding | N/A |
| Bottle – unit of product usage | N/A |
| Brain stem laceration with open intracranial wound AND no loss of consciousness | Brain stem laceration with open intracranial wound |
| Bread barium swallow | Fluoroscopy of esophagus and stomach with barium contrast coated bread swallow |
| Breast screening requested | Screening for malignant neoplasm of breast requested |
| Breathy whispered-intermittent group | Breathy voice quality |
| Brevibacterium liquefaciens | Glutamicibacter nicotianae |
| Brevibacterium refuscens | N/A |
| Buccal administration of treatment | N/A |
| Bulge test | N/A |
| Calcium/bismuth antacids A-Z | N/A |
| Camouflaging preparations A-Z | N/A |
| Can – unit of product usage | N/A |
| Cancer home care pack given | N/A |
| Candida inconspicua or Candida krusei | N/A |
| Candida inconspicua or Candida krusei or Candida lambica | N/A |
| Candida, not Candida albicans | Candida species not Candida albicans |
| Capsule – unit of product usage | N/A |
| Carcinoma in situ of breast and genitourinary system | N/A |
| Cardiac radio-frequency ablation system | N/A |
| Cardiological test categorized by action status | N/A |
| Caries active | N/A |
| Caries inactive | N/A |
| Castration anxiety complex | N/A |
| Cat scratch injury | N/A |
| Catabacteriaceae | Christensenellaceae |
| Category A biological agent | N/A |
| Category B biological agent | N/A |
| Category C biological agent | N/A |
| Caulobacter crescentus | Caulobacter vibrioides |
| Causes of injury and poisoning | N/A |
| CD8+HLA-DR+ cell | CD8+HLA-DR+ cell |
| Cerebellar laceration with open intracranial wound AND no loss of consciousness | Cerebellar laceration with open intracranial wound |
| Cerebellopontine angle meningioma | N/A |
| Cerebral degenerations usually manifest in childhood | N/A |
| Cerebral depression in newborn | N/A |
| Cerulin | N/A |
| Chemical pathology test categorized by action status | N/A |
| Chemotherapy AND/OR radiation therapy prior to lymphadenectomy | N/A |
| Child height = 0.4th centile | Child height = 0.4th centile |
| Chlamydophila | Chlamydia |
| Chlamydophila psittaci variant bovis | N/A |
| Chlamydophila psittaci variant felis | N/A |
| Chlamydophila psittaci variant ovis | N/A |
| Chlorhexidine A-H | N/A |
| Chlorhexidine I-Z | N/A |
| Chlorobaculum chlorovibrioides | Chlorobium chlorovibrioides |
| Chromosome | N/A |
| Chronic disease of hematopoietic system | N/A |
| Chronic disease of immune system | N/A |
| Chronic granulomatous tuberculosis | N/A |
| Cineswallow | Videofluoroscopy swallow |
| Circulatory topical preparations A-Z | N/A |
| Cladosporium mansonii | Exophiala castellanii |
| Class Actinobacteria | Actinomycetes |
| Cleft tongue | N/A |
| Client participation | N/A |
| Clinical manifestation of carnosinase deficiency | N/A |
| Closed contusion | N/A |
| Clostridium species a-f | N/A |
| Clostridium species g-p | N/A |
| Clostridium species q-z | N/A |
| Clotting and bleeding disorders | N/A |
| Coccidian parasite | N/A |
| Coelozoic parasite | N/A |
| Colon double contrast examination | Fluoroscopy of colon with barium and air contrast enema |
| Comamonas acidovorans or Comamonas testosteroni | N/A |
| Commensal parasite | N/A |
| Common eye AND/OR eyelid symptom | N/A |
| Common pilum | N/A |
| Communicable disease | N/A |
| Community special services assessment | N/A |
| Community special services education | N/A |
| Community special services management | N/A |
| Complex procedure | N/A |
| Complex relationship building | N/A |
| Complication of filtering bleb | Disorder of filtering bleb |
| Compound analgesics A-L | N/A |
| Compound analgesics M-Z | N/A |
| Compound antidepressants A-Z | N/A |
| Compound antispasmodics A-Z | N/A |
| Compound bronchodilators A-Z | N/A |
| Compound proprietary antacids A-C | N/A |
| Compound proprietary antacids D-L | N/A |
| Compound proprietary antacids M-Z | N/A |
| Concussion with mental confusion AND/OR disorientation without loss of consciousness | Concussion injury of brain |
| Concussion with no loss of consciousness | N/A |
| Congenital anomaly – oral/respiratory | N/A |
| Congenital anomaly of fetal head bones | N/A |
| Congenital lordosis/scoliosis | N/A |
| Congenital melanocytic nevus | Pigmented nevus |
| Contagious disease | N/A |
| Contraceptive coil | N/A |
| Coriobacteridae | N/A |
| Corneal deposit associated with metabolic disorder | Corneal deposits due to metabolic disorder |
| Cornual pregnancy | N/A |
| Corrosion of pharynx | N/A |
| Cortex contusion with open intracranial wound, with no loss of consciousness | Cortex contusion with open intracranial wound |
| Cortex laceration with open intracranial wound, with no loss of consciousness | Cortex laceration with open intracranial wound |
| Crossed hemianopsia | N/A |
| Crystalline corneal dystrophy | N/A |
| Cup | N/A |
| Cursive (running) epilepsy | Epilepsy |
| Cutaneous sarcoidosis | N/A |
| Cyclozoonosis | N/A |
| Cystoscopy and bulb catheter ureteropyelography | N/A |
| Cystoscopy and retrograde pyelography | Cystoscopy and fluoroscopic retrograde pyelography with contrast |
| Death or significant injury of a patient or staff member resulting from a physical assault (i.e., battery) that occurs within or on the grounds of the healthcare facility | N/A |
| Decision-making epilepsy | Reflex epilepsy with thinking-induced seizures |
| Decorative product | N/A |
| Decorative products causing toxic effect | N/A |
| Decreased level (laboratory finding) | N/A |
| Defecography with barium enema | Fluoroscopic defecating proctography with barium enema |
| Deficiency of aminoacyl-histidine dipeptidase | N/A |
| Deficiency of malate oxidase | Deficiency of malate dehydrogenase (quinone) |
| Deficiency of nitrate reductase | N/A |
| Deficiency of pectinesterase | N/A |
| Deficiency of peptidase a | Deficiency of cytosol non-specific dipeptidase |
| Deficiency of phosphomonoesterase | N/A |
| Deficiency of sulfatase | N/A |
| Degrees of severity | N/A |
| Delivered by cesarean section – pregnancy at term | N/A |
| Dental caries activity – finding | N/A |
| Dependence on seeing eye dog | Dependent on guide dog |
| Derived flow, non-valve | N/A |
| Desulfurococcus mobilis | Desulfurococcus mucosus |
| Device crossed septum | N/A |
| Device inserted into sheath | N/A |
| Device withdrawn and / or removed | Device removed |
| Dextrocardia/situs inversus finding | N/A |
| Diagnostic imaging and nuclear medicine procedures | N/A |
| Dietetic poisoning | N/A |
| Difficulty transferring between wheelchair and toilet | N/A |
| Digestive tract and abdominal organs | N/A |
| Dipodascus geotrichum | Geotrichum galactomycetum |
| Disc – unit of product usage | N/A |
| Discoid atelectasis | N/A |
| Disease of blood AND/OR blood-forming organ | N/A |
| Disease transmitted by tick | N/A |
| Disorder of body wall and cavities | N/A |
| Disorder of hematopoietic system | N/A |
| Disorder of immune system | N/A |
| Disorder of intra-aortic pulsation balloon | N/A |
| Disorder of optic chiasm associated with vascular disorder | Disorder of optic chiasm due to vascular disorder |
| Disorder of pregnancy / labor / delivery / puerperium | N/A |
| Disorder of system | N/A |
| Disorder of the third, fourth and sixth nerves and of eye movements | N/A |
| Disorder of visual pathways associated with vascular disorder | N/A |
| Dissociated spinal nerve sensory loss | N/A |
| Diuretics+potassium supplement A-Z | N/A |
| Division of bone of thorax, ribs or sternum | N/A |
| Does not transfer between wheelchair and toilet | N/A |
| Does transfer between wheelchair and toilet | N/A |
| Double contrast barium meal | Fluoroscopy of upper gastrointestinal tract with barium and air contrast |
| Double contrast barium swallow | Fluoroscopy of esophagus and stomach with barium and air contrast swallow |
| Doula | N/A |
| Downslipped innominate | N/A |
| Dressing – unit of product usage | N/A |
| Dressing medicated with leptospermum honey | N/A |
| Drug groups primarily used in obstetrics, gynecological and urinary tract disorders overdose | N/A |
| Drug groups primarily used in obstets, gyne. and urinary tract disorders poisoning | N/A |
| Drug groups primarily used obs, gyn.+ urinary tract dis adverse reaction | N/A |
| Drug monitoring procedure AND/OR toxicology screen | N/A |
| Drug-induced coagulation inhibitor | N/A |
| Dysfunctional voiding | N/A |
| Ear, nose and throat/auditory test categorized by action status | N/A |
| Ebstein’s anomaly of right atrioventricular valve | N/A |
| Eclamptic seizure | Acute symptomatic epileptic seizure due to eclampsia |
| Ectopic ACTH | Ectopic ACTH secretion |
| Ectopic chorionic gonadotropin secretion | Ectopic human chorionic gonadotropin secretion |
| Ectopic releasing factor | N/A |
| Ectozoic parasite | N/A |
| Education about postcoital contraceptive | N/A |
| Elastic diachylon ventilated bandage | Elastic bandage |
| Elizabethkingia endophytica | N/A |
| Emmonsia parva | Blastomyces parvus |
| Emollients/barrier creams: A-E | N/A |
| Emollients/barrier creams: F-O | N/A |
| Emollients/barrier creams: P-Z | N/A |
| Emulsion proteinuria | N/A |
| Encephalitis due to tick-borne encephalitis virus subgroup | N/A |
| Endocrine / nutritional / metabolic disorder | N/A |
| Endocrine, breast and special senses | N/A |
| Endometriosis of pelvic peritoneum | N/A |
| Endomyces geotrichum | Geotrichum galactomycetum |
| Endomycopsis | Saccharomycopsis |
| Endoscopic primary repair of femoral hernia | Endoscopic repair of femoral hernia |
| Endoscopic primary repair of inguinal hernia | Endoscopic repair of inguinal hernia |
| Endoscopic retrograde pancreatography via accessory ampulla of Vater | Endoscopic retrograde pancreatography via accessory ampulla of Vater using fluoroscopic guidance with contrast |
| Enema – unit of product usage | N/A |
| ENT test finding | N/A |
| Enteropathogen | N/A |
| Enteropathogenic bacteria | N/A |
| Enteropathogenic virus | N/A |
| Entire breast and endocrine system | N/A |
| Entire Fleischmann’s bursa | N/A |
| Entire granulosum of ovarian follicle | N/A |
| Entire left horn of uterus | N/A |
| Entire lymphocytic tissue | N/A |
| Entire pelvic peritoneal space | N/A |
| Entire physiologic cup of optic disc | Entire optic disc |
| Entire product of conception of ectopic pregnancy | N/A |
| Entire regional back | N/A |
| Entire regional skeletal muscle | N/A |
| Entire respiratory system and intrathoracic structure | N/A |
| Entire right horn of uterus | N/A |
| Entire throat | Structure of pharynx and/or larynx |
| Entozoic parasite | N/A |
| Environmental management: attachment process | N/A |
| Enzymes A – L | N/A |
| Enzymes M – Z | N/A |
| Equivocal biochemistry finding | N/A |
| Equivocal hematology finding | N/A |
| Equivocal laboratory finding | N/A |
| Equivocal microbiology finding | N/A |
| Esophageal motility study | N/A |
| Esophageal motility study with acid perfusion studies | N/A |
| Establishment of rapport | N/A |
| Establishment of trust | N/A |
| Estate agent | N/A |
| Estradiol 1.04 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 1.042 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 1.56 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 1.563 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 1.667 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch | N/A |
| Estradiol 2.08 microgram/hour and norethindrone acetate 10.4 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 2.08 microgram/hour and norethindrone acetate 5.83 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 2.08 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 2.083 microgram/hour and norethindrone acetate 10.417 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 2.083 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 2.083 microgram/hour prolonged-release vaginal ring | Estradiol 50 microgram/24 hour prolonged-release vaginal ring |
| Estradiol 2.5 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 3.125 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 3.13 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 3.333 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 312.5 nanogram/hour prolonged-release vaginal ring | N/A |
| Estradiol 4.167 microgram/hour prolonged-release transdermal patch | N/A |
| Estradiol 4.167 microgram/hour prolonged-release vaginal ring | Estradiol 100 microgram/24 hour prolonged-release vaginal ring |
| Estradiol 583 nanogram/hour prolonged-release transdermal patch | N/A |
| Ethinyl estradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch | N/A |
| Excision of thyroglossal duct fistula | N/A |
| Exposure to communicable disease | N/A |
| Exposure to electric current and radiation | N/A |
| Expulsion intrauterine contraceptive device | N/A |
| Exserohilum mcginnisii | Exserohilum rostratum |
| Extra-articular plastic replacement of intra-articular ligament | Extra-articular stabilization of joint |
| Extra-articular prosthetic augmentation of intra-articular ligament | Extra-articular stabilization of joint using prosthetic ligament |
| Extreme prematurity of infant | N/A |
| Facial milia, lobate tongue, lingual and labial frenula syndrome | Oro-facial digital syndrome type 1 |
| Facultative parasite | N/A |
| Failed attempted termination of pregnancy complicated by shock | N/A |
| Fallopian tube endoscopy | N/A |
| Fear of heart attack | N/A |
| Female infertility associated with anovulation | N/A |
| Fetal / neonatal / perinatal disorder | N/A |
| Fetal and newborn blood disorders | N/A |
| Fibrous mediastinitis caused by radiation | N/A |
| Filler | N/A |
| Filler causing toxic effect | N/A |
| Filling material | N/A |
| Finding / disorder | N/A |
| Finding / observation / clinical history | N/A |
| Finding related to ability to transfer between wheelchair and toilet | N/A |
| Finding relating to grief and dying | N/A |
| First degree | N/A |
| Flea-borne infectious disease | N/A |
| Flexibacter aurantiacus | Flavobacterium johnsoniae subsp. aurantiacum |
| Flexible-end laryngoscope blade | N/A |
| Flow in veins | N/A |
| Fluoride 1.1 mg oral tablet | N/A |
| Fluoride 2.2 mg oral tablet | N/A |
| Fluoride 550 microgram oral tablet | N/A |
| Fluoride ion | N/A |
| Fluoroscopic gastrointestinal tract loopography | N/A |
| Fluoroscopy guided therapeutic contrast enema for reduction of intussusception of colon | Fluoroscopy guided reduction of intussusception of colon with barium enema |
| Fluoroscopy of barium small bowel meal and follow through | Fluoroscopic barium meal and follow through |
| Fomite transmitted infectious disease | N/A |
| Fonsecaea compacta | Fonsecaea pedrosoi |
| Food, vitamin, electrolyte and inorganic salt overdose | N/A |
| Food, vitamin, electrolyte and inorganic salt poisoning | N/A |
| Foods, vitamins, electrolytes and inorganic salts allergy | N/A |
| Foods, vitamins, electrolytes inorganic salts adverse reaction | N/A |
| Frozen pelvis syndrome | N/A |
| Function AND/OR dysfunction of axon | N/A |
| Fusarium semitectum | Fusarium incarnatum |
| Gastric acidity increasers A-Z | N/A |
| Gastrin challenge tests | N/A |
| Gastrografin enema | Fluoroscopy of lower gastrointestinal tract with gastrografin contrast enema |
| Gastrografin meal | Fluoroscopy of gastrointestinal tract using water soluble contrast swallow and meal |
| Gastrografin swallow | N/A |
| Gastrointestinal tract loopogram | N/A |
| Gastrointestinal tract test categorized by action status | N/A |
| Genetic, molecular AND/OR cellular finding | N/A |
| Genitalia, sexual function and urinary tract observations | N/A |
| Genitourinary test categorized by action status | N/A |
| Genotyping | N/A |
| Geobacillus gargensis | Geobacillus thermocatenulatus |
| Gingival administration of treatment | N/A |
| Glial tumor of spinal cord | N/A |
| Gluconacetobacter hansenii | Komagataeibacter hansenii |
| Glucose dependent insulinotropic peptide | N/A |
| Granisetron 129.167 microgram/hour prolonged-release transdermal patch | N/A |
| Granuloma gravidarum | N/A |
| Grief and dying observables | N/A |
| Hallux valgus due to metatarsus primus varus | N/A |
| Halomonas halodurans | Cobetia marina |
| Halomonas johnsoniae | Halomonas hamiltonii |
| Head pressing | N/A |
| Headache due to acute angle closure glaucoma | Headache due to acute angle closure |
| Health encounter sites | N/A |
| Heavy metal agonist poisoning | N/A |
| Helminth | N/A |
| Hemangiomas and lymphangiomas of any site | N/A |
| Hematologic disorder in newborn | N/A |
| Hematological sample | N/A |
| Hematology finding absent | N/A |
| Hematology finding negative | N/A |
| Hematology finding present | N/A |
| Hematology screening test | Screening for hematological disorder |
| Hematology test categorized by action status | N/A |
| Hematozoic parasite | N/A |
| Hemostatic gauze product | N/A |
| Hepcidin | N/A |
| Heptacarboxylic acid porphyrin | N/A |
| Hexacarboxylic acid porphyrin | N/A |
| Hexamethylene diisocyanate | N/A |
| High-pitch group | High pitched voice |
| Hind brain laceration with open intracranial wound, with no loss of consciousness | Hind brain laceration with open intracranial wound |
| Hirsuties papillaris penis | N/A |
| Histology laboratory test | N/A |
| Histopathology test categorized by action status | N/A |
| History of active tuberculosis | N/A |
| History of acute angle closure glaucoma | History of acute angle closure |
| History of aspirin exacerbated respiratory disease | History of non-steroidal anti-inflammatory drug exacerbated respiratory disease |
| History of nephrectomy | N/A |
| History taking status | N/A |
| Home care AND/OR social service | N/A |
| Home help requested | Home help requested |
| Hormones and their metabolites and precursors A – G | N/A |
| Hormones and their metabolites and precursors H – S | N/A |
| Hormones and their metabolites and precursors T – Z | N/A |
| Household product causing toxic effect | N/A |
| Housing – awaiting action | N/A |
| Human arthropod parasite | N/A |
| Human leukocyte antigen B5701 detected | N/A |
| Human parasite | N/A |
| Husky-breathy whispered-continuous group | N/A |
| Hypergammaglobulinemia | N/A |
| Hyperkinesis with developmental delay | N/A |
| Hypertrophic glandular gastritis | Hypertrophic gastritis |
| Hypoglycemia-induced convulsion | Acute symptomatic epileptic seizure due to hypoglycemia |
| Ileostomy enema | N/A |
| Immunology finding | N/A |
| Immunology finding present | N/A |
| Immunology test categorized by action status | N/A |
| Implant – unit of product usage | N/A |
| Implantation of audiant bone conductor | Fitting of anchored bone-conduction hearing aid to bone anchored fixture |
| Implantation of prosthesis or prosthetic device of joint of toe | Prosthetic arthroplasty of toe |
| Inanimate samples and substances | N/A |
| Increased level (laboratory finding) | N/A |
| Infection caused by Aspergillus maydis | N/A |
| Infection caused by Aspergillus notatum | N/A |
| Infection caused by Aspergillus phialiseptus | Infection by Aspergillus fumigatus |
| Infection caused by Aspergillus taumanii | N/A |
| Infection of body wall and cavities | N/A |
| Infection of peritoneal dialysis catheter | N/A |
| Infectious agent | N/A |
| Inferior pubis | N/A |
| Inflammation of vulva | N/A |
| Inflammatory AND/OR infective disease of the central nervous system | N/A |
| Influenza with non-respiratory manifestation | N/A |
| Inhalations A-Z | N/A |
| Injection of filling material into eyelid | Injection of soft tissue filling material into eyelid |
| Injection of small joint | N/A |
| Injury of cervical region of back | N/A |
| Insect-transmitted infectious disease | N/A |
| Insert – unit of product usage | N/A |
| Insertion of pleural tube drain | N/A |
| Insertion of underwater seal chest drain | N/A |
| Instant barium enema | N/A |
| Intentional alternative medicine overdose | N/A |
| Intentional alternative medicine poisoning | N/A |
| Intercostal drain | N/A |
| Internal parasite | N/A |
| Intestinal ameba | N/A |
| Intestinal ciliate | N/A |
| Intestinal coccidia | N/A |
| Intestinal flagellate | N/A |
| Intestinal microsporidian | N/A |
| Intestinal nematode | N/A |
| Intestinal protozoan | N/A |
| Intestinal trematode | N/A |
| Intra-aortic balloon infection | Infection associated with intra-aortic balloon catheter |
| Intra-aortic balloon thrombosis | N/A |
| Intracavernous administration of treatment | N/A |
| Intracellular parasite | N/A |
| Intraspinal administration of treatment | N/A |
| Intrauterine pressure test | N/A |
| Intravenous administration of treatment | N/A |
| Intravenous cystography | N/A |
| Intravesical administration of treatment | N/A |
| Introduction into skin | Procedure on skin |
| Introduction into subcutaneous tissue | N/A |
| Isospora canis | Cystoisospora canis |
| Isospora felis | Cystoisospora felis |
| Isospora ohioensis | Cystoisospora ohioensis |
| Isospora rivolta | Cystoisospora rivolta |
| Isotope static scan kidneys | Radionuclide static scan of kidney |
| Karyozoic parasite | N/A |
| Kerasin thesaurismosis | N/A |
| Keratitis due to tuberculosis | N/A |
| Klebsiella singaporensis | Klebsiella variicola |
| Lab result outside established criteria | N/A |
| Laboratory finding absent | N/A |
| Laboratory finding present | N/A |
| Lactobacillus kefir | Lentilactobacillus kefiri |
| Lactobacillus sanfrancisco | Fructilactobacillus sanfranciscensis |
| Lactosphaera | Trichococcus |
| Latent schizophrenia | Schizotypal personality disorder |
| Latent schizophrenia in remission | N/A |
| Leaking Tenckhoff catheter | N/A |
| Left metatarsus primus varus | N/A |
| Leishmania mexicana garnhami | Leishmania garnhami |
| Leishmania mexicana venezuelensis | Leishmania venezuelensis |
| Lente human insulin | N/A |
| Leptospira interrogans, serogroup Pomona | N/A |
| Ligamentous strain | Sprain of ligament |
| Lightening of fetus | N/A |
| Limited duction associated with other condition of eye | N/A |
| Livedo reticularis without ulceration | Livedo reticularis |
| Liver moderate laceration with open wound into cavity | N/A |
| Locomotor test categorized by action status | N/A |
| LOINC – SNOMED CT Cooperation Project module | N/A |
| Longitudinal fetal presentation | N/A |
| Loopogram of colon | N/A |
| Louse-borne infectious disease | N/A |
| Lowered biochemistry finding | N/A |
| Lowered hematology finding | N/A |
| Lowered laboratory finding | N/A |
| Lowered microbiology finding | N/A |
| Low-pitch hoarse group | N/A |
| Lozenge – unit of product usage | N/A |
| Lung trematode | N/A |
| Lymphocytic portal hepatitis | Lymphocytic portal hepatitis |
| Lymphocytic tissue structure | N/A |
| Lymphoepithelial tumor of skin | N/A |
| Lymphoid system subdivision | Lymphoid system structure |
| Lysinuric protein intolerance, type 2 | Lysinuric protein intolerance |
| Malformation or hamartoma of apocrine sweat gland apparatus | N/A |
| Malformation or hamartoma of eccrine sweat gland apparatus | N/A |
| Malformation or hamartoma of pilosebaceous apparatus | N/A |
| Malformation or hamartoma of skin appendage | N/A |
| Malignant melanoma of trunk (excluding scrotum) | N/A |
| Malignant neoplasm of digestive organs and peritoneum | N/A |
| Malignant neoplasm of lower lip, buccal aspect | N/A |
| Malignant neoplasm of lower lip, external | N/A |
| Malignant neoplasm, overlapping lesion of connective and soft tissue | N/A |
| Malignant tumor of mesothelial and soft tissue | N/A |
| Mammalian schistosome | N/A |
| Marinibacillus | Jeotgalibacillus |
| Marker cystogram | N/A |
| Marker urogram | N/A |
| Marshmallow barium swallow | Fluoroscopy of esophagus with barium contrast coated marshmallow swallow |
| Maternal death or serious disability associated with labor or delivery in a low-risk pregnancy while being cared for in a healthcare facility | N/A |
| Maternal pregnancy problem | N/A |
| Mazoplasia | Fibrocystic disease of breast |
| Mcg/m2 | N/A |
| Median nail dystrophy | N/A |
| Median nail dystrophy of Heller | N/A |
| Meetings and conferences | N/A |
| Megaloblastic anemia due to increased requirements | N/A |
| Melanocytic nevi of ear and external auditory canal | N/A |
| Melanocytic nevi of eyelid, including canthus | N/A |
| Melanocytic nevi of lower limb, including hip | N/A |
| Melanocytic nevi of scalp and neck | N/A |
| Melanocytic nevi of upper limb, including shoulder | N/A |
| Menophania | Menarche |
| Menosepsis | N/A |
| Menstrual problem | N/A |
| Mesenteric saponification | N/A |
| Metalloporphyrin agent | N/A |
| Metatarsus primus varus | N/A |
| Metazoonosis | N/A |
| Methods of tracheal or bronchial intubation | N/A |
| Microbiology finding absent | N/A |
| Microbiology finding present | N/A |
| Microbiology test categorized by action status | N/A |
| Microbispora mesophila | Sphaerimonospora mesophila |
| Microhepatia | Congenital microhepatia |
| Microsporosis nigra | N/A |
| Microsporum canis var. distortum | Microsporum equinum |
| Microsporum gallinae | Lophophyton gallinae |
| Microsporum vanbreuseghemii | Lophophyton gallinae |
| Mid-stream urine specimen obtained by single catheterization of urinary bladder | N/A |
| Miliary tuberculosis | N/A |
| Milwaukee brace | N/A |
| Minimally invasive procedure | N/A |
| Minor skin infection preparations A-Z | N/A |
| Miokamycin | N/A |
| Mite-borne hemorrhagic fever | N/A |
| Mite-borne infectious disease | N/A |
| Mitochondrial 2-methylacetoacetyl-CoA thiolase deficiency – potassium stimulated | N/A |
| Mixed vaccine poisoning, excluding pertussis | N/A |
| Moderate to late prematurity of infant | N/A |
| Molimen climacterium virile | Male climacteric |
| Monosporella | Metschnikowia |
| More supplement and complete foods A-Z | N/A |
| Mosquito-borne alphavirus encephalitis | N/A |
| Mosquito-borne alphavirus fever | N/A |
| Mosquito-borne alphavirus hemorrhagic fever | N/A |
| Mosquito-borne arboviral fever | N/A |
| Mosquito-borne bunyamwera group virus fever | N/A |
| Mosquito-borne bunyavirus hemorrhagic fever | N/A |
| Mosquito-borne bwamba group virus fever | N/A |
| Mosquito-borne California group virus fever | N/A |
| Mosquito-borne flavivirus encephalitis | N/A |
| Mosquito-borne flavivirus fever | N/A |
| Mosquito-borne flavivirus hemorrhagic fever | N/A |
| Mosquito-borne guama group virus fever | N/A |
| Mosquito-borne hemorrhagic fever | N/A |
| Mosquito-borne infectious disease | N/A |
| Mosquito-borne orbivirus fever | N/A |
| Mosquito-borne orthobunyavirus encephalitis | N/A |
| Mosquito-borne orthobunyavirus fever | N/A |
| Mosquito-borne rhabdovirus fever | N/A |
| Mosquito-borne serogroup C bunyavirus fever | N/A |
| Mosquito-borne simbu group virus fever | N/A |
| Mosquito-borne viral encephalitis | N/A |
| Mouth, abdomen and bowel observations | N/A |
| Mucor rouxianus | Rhizopus arrhizus |
| Mucor spinosus | N/A |
| Multidrug-resistant Salmonella paratyphi | Multidrug-resistant Salmonella Paratyphi |
| Multiple cysts of pulmonary system | N/A |
| Multisystem disorder A-B | N/A |
| Multisystem disorder C-D | N/A |
| Multisystem disorder E-F | N/A |
| Multisystem disorder G-H | N/A |
| Multisystem disorder I-J | N/A |
| Multisystem disorder K-L | N/A |
| Multisystem disorder M-N | N/A |
| Multisystem disorder O-P | N/A |
| Multisystem disorder Q-R | N/A |
| Multisystem disorder S-T | N/A |
| Multisystem disorder U-V | N/A |
| Multisystem disorder W-X | N/A |
| Multisystem disorder Y-Z | N/A |
| Multisystem therapy | N/A |
| Musculoskeletal functions and activities | N/A |
| Musicogenic seizure | Epileptic seizures induced by music |
| Mycobacterium paratuberculosis | Mycobacterium avium subsp. paratuberculosis |
| Mycoplasma haemosuis | Mycoplasma suis |
| Myelomenia | Vicarious menstruation |
| Myelopathy due to acute infarction of spinal cord | N/A |
| Narcotic withdrawal epilepsy | Acute symptomatic epileptic seizure due to opioid withdrawal |
| Nasogastric administration of treatment | N/A |
| Negative biochemistry finding | N/A |
| Negative immunology finding | N/A |
| Negative laboratory finding | N/A |
| Negative microbiology finding | N/A |
| Negative virology finding | N/A |
| Negative/double contrast cystography | N/A |
| Negative/double contrast pyelogram | N/A |
| Neonatal hematologic disorder | N/A |
| Neonatal metabolic acidemia | N/A |
| Neonatal seizure complicating infection | Neonatal acute symptomatic epileptic seizure due to acute infectious disease |
| Neoplasm of mesothelial tissue of site other than pleura AND pericardium | N/A |
| Neoplasm of uncertain behavior of histiocytic and mast cells | N/A |
| Neoplasm of uncertain behavior of pleura, thymus and mediastinum | N/A |
| Neoplasm of uncertain behavior of stomach, intestines and rectum | N/A |
| Neoplasm of uncertain behavior of trachea, bronchus and lung | N/A |
| Nephrostogram | N/A |
| Neuroaxonal leukodystrophy | Hereditary diffuse leukoencephalopathy with spheroids |
| Neurological decompression syndrome | N/A |
| Neurological sample | N/A |
| Neurological symptom changes | N/A |
| Neurological test categorized by action status | N/A |
| Neuronal cell marker | N/A |
| Never feeling insecure about caring for child | Feels secure in caring for child |
| Nicotine 1.563 mg/hour prolonged-release transdermal patch | N/A |
| Nicotine 291.667 microgram/hour prolonged-release transdermal patch | N/A |
| Nicotine 312.5 microgram/hour prolonged-release transdermal patch | N/A |
| Nicotine 458 microgram/hour prolonged-release transdermal patch | N/A |
| Nicotine 583.333 microgram/hour prolonged-release transdermal patch | N/A |
| Nicotine 625 microgram/hour prolonged-release transdermal patch | N/A |
| Nicotine 875 microgram/hour prolonged-release transdermal patch | N/A |
| Nicotine 917 microgram/hour prolonged-release transdermal patch | N/A |
| Nicotine 937.5 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 200 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 208.333 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 300 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 400 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 416.667 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 600 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 625 microgram/hour prolonged-release transdermal patch | N/A |
| Nitroglycerin 800 microgram/hour prolonged-release transdermal patch | N/A |
| No abnormal biochemistry finding detected | N/A |
| No abnormal laboratory finding detected | N/A |
| No abnormal microbiology finding detected | N/A |
| No known relatives | N/A |
| Noninfectious, erythematous, papular AND/OR squamous disease | N/A |
| Noninfectious, vesicular AND/OR bullous disease | N/A |
| Non-medicinal substance | N/A |
| Normal biochemistry finding | N/A |
| Normal immunology finding | N/A |
| Normal microbiology finding | N/A |
| Normal urinary stream | N/A |
| Nursing attributes A – L | N/A |
| Nursing attributes M – S | N/A |
| Nursing attributes T – Z | N/A |
| Obligate parasite | N/A |
| Observation hip syndrome | Transient synovitis of hip |
| Obstetrics and gynecology sample | N/A |
| Oculocephalogyric reflex | N/A |
| Oculodento-osseous dysplasia | N/A |
| Oculodento-osseous dysplasia – mild type | Oculodentodigital syndrome |
| Oculodento-osseous dysplasia – severe type | Oculodentodigital syndrome |
| Oculoskeletal dysplasia | N/A |
| Offspring leaves home | N/A |
| On housing list | N/A |
| On urgent housing list | N/A |
| Oral administration of treatment | N/A |
| Oral cavity, dental and salivary gland disorder | N/A |
| Oral cavity, dental and salivary gland injury | N/A |
| Oral cavity, salivary glands and jaw diseases | N/A |
| Oral dermatological agent allergy | N/A |
| Orbital deformity associated with craniofacial deformity | N/A |
| Organ or tissue harvesting and transplantation procedures | N/A |
| Organic compounds A-C | N/A |
| Organic compounds D-H | N/A |
| Organic compounds I-R | N/A |
| Organic compounds S-Z | N/A |
| Orthodontic extraoral headgear | N/A |
| Ossicular prosthesis, total | N/A |
| Osteitis deformans and osteopathies associated with other diseases | N/A |
| Otto’s pelvis | Intrapelvic protrusion of acetabulum |
| Oxybutynin 162 microgram/hour prolonged-release transdermal patch | N/A |
| Oxygen administration face tent | N/A |
| Packet – unit of product usage | N/A |
| Pad – unit of product usage | N/A |
| Paecilomyces lilacinum | Purpureocillium lilacinum |
| Paenibacillus larvae ss pulvifaciens | Paenibacillus larvae |
| Pancreatography during surgery | Intraoperative imaging of pancreas with contrast |
| Pancuronium sodium | N/A |
| Papular, squamous and granulomatous eruptions of skin | N/A |
| Paralysis absent | No paralysis |
| Parasite | N/A |
| Parasitic fluke | N/A |
| Parasitic nematode | N/A |
| Parenteral route | N/A |
| Parkinson’s facies | N/A |
| Pastille – unit of product usage | N/A |
| Patch – unit of product usage | N/A |
| Pathogenic organism | N/A |
| Patient advised about exposure to the sun | N/A |
| Patient death or serious disability associated with a burn incurred from any source while being cared for in a healthcare facility | N/A |
| Patient death or serious disability associated with a hemolytic reaction due to the administration of ABO-incompatible blood or blood products | N/A |
| Patient death or serious disability associated with a medication error | N/A |
| Patient death or serious disability associated with an electric shock while being cared for in a healthcare facility | N/A |
| Patient death or serious disability associated with hypoglycemia, the onset of which occurs while the patient is being cared for in a healthcare facility | N/A |
| Patient death or serious disability associated with intravascular air embolism that occurs while being cared for in a healthcare facility | N/A |
| Patient death or serious disability associated with patient elopement (disappearance) for more than four hours | N/A |
| Patient death or serious disability associated with the use of contaminated drugs, devices, or biologics provided by the healthcare facility | N/A |
| Patient death or serious disability associated with the use of restraints or bedrails while being cared for in a healthcare facility | N/A |
| Patient death or serious disability associated with the use or function of a device in patient care, in which the device is used or functions other than as intended | N/A |
| Patient death or serious disability due to spinal manipulative therapy | N/A |
| Pattern sensitive seizure | Epileptic seizures induced by patterns |
| Patulous umbilicus | Distension of abdomen |
| Pediococcus lolii | Pediococcus acidilactici |
| Pellet – unit of product usage | N/A |
| Pelvic peritoneal space | N/A |
| Pendulous right breast | N/A |
| Penicillium bertai | Penicillium citreonigrum |
| Penile sheath | N/A |
| Peptostreptococcus harei | Peptoniphilus harei |
| Peptostreptococcus ivorii | Peptoniphilus ivorii |
| Perceptual disturbances and seizures co-occurrent and due to alcohol withdrawal | Acute symptomatic epileptic seizure due to alcohol withdrawal |
| Perceptual disturbances and seizures co-occurrent and due to hypnotic withdrawal | Acute symptomatic epileptic seizure due to hypnotic withdrawal |
| Perceptual disturbances and seizures co-occurrent and due to psychoactive substance withdrawal | Acute symptomatic epileptic seizure due to substance withdrawal |
| Perceptual disturbances and seizures co-occurrent and due to sedative withdrawal | Acute symptomatic epileptic seizure due to sedative withdrawal |
| Percutaneous cyst puncture and cystogram | N/A |
| Percutaneous cystography | N/A |
| Perinatal fetal and/or neonatal disorder | N/A |
| Perinatal hematologic problems | N/A |
| Peripheral body temperature | N/A |
| Peroneus longus rupture | N/A |
| Pharmaceutical excipient poisoning | N/A |
| Phialophora parasitica | Phaeoacremonium parasiticum |
| Phosphoglycerokinase | N/A |
| Phosphoglycerokinase deficiency | N/A |
| Physical examination status | N/A |
| Pilum | N/A |
| Pintid | N/A |
| Placido disk | N/A |
| Plain X-ray guided intravenous pyelogram | Plain X-ray pyelography with intravenous contrast |
| Plasmodium species not Plasmodium falciparum | Plasmodium species not Plasmodium falciparum |
| Plethysmometry | N/A |
| Pneumocystogram | N/A |
| Poisoning / injury | N/A |
| Poisoning by antiallergic AND/OR antiemetic drug | N/A |
| Poisoning by mixed bacterial vaccine except combinations with a pertussis component | N/A |
| Poisoning by uric acid metabolism drug | N/A |
| Poisoning by vaccine AND/OR biological substance | N/A |
| Poisoning by water AND/OR mineral metabolism drug | N/A |
| Poisoning of undetermined intent by non-drug substance | N/A |
| Pooled specimen from vaginal introitus and rectal swab | Combined specimen from swab of rectum and vaginal introitus |
| Porphyromonas cansulci | Porphyromonas crevioricanis |
| Positive biochemistry finding | N/A |
| Positive hematology finding | N/A |
| Positive immunology finding | N/A |
| Positive laboratory finding | N/A |
| Positive microbiology finding | N/A |
| Post-renal renal failure | N/A |
| Posttraumatic seizure | Acute symptomatic epileptic seizure due to traumatic brain injury |
| Potassium sparing compound diuretics A-Z | N/A |
| Prefilled syringe – unit of product usage | Syringe |
| Premature infant | Preterm infant less than 37 completed weeks gestation |
| Premature infant 28-37 weeks | N/A |
| Previous cleft palate repair | N/A |
| Primary allograft augmentation extra-articular ligament | Augmentation of extra-articular ligament using allograft |
| Primary anterior decompression of cervical spinal cord | Anterior decompression of cervical spinal cord |
| Primary anterior decompression of cervical spinal cord and fusion | Anterior decompression of cervical spinal cord and fusion |
| Primary arthroscopic allograft ligament augmentation | Arthroscopic augmentation of ligament using allograft |
| Primary arthroscopic autograft ligament augmentation | Arthroscopic augmentation of ligament using autograft |
| Primary arthroscopic ligament repair | Arthroscopic repair of ligament |
| Primary arthroscopic prosthetic ligament augmentation | Arthroscopic augmentation of ligament using prosthetic ligament |
| Primary arthroscopic reattachment of ligament | Arthroscopic reattachment of ligament |
| Primary arthroscopic xenograft ligament augmentation | Arthroscopic augmentation of ligament using xenograft |
| Primary autograft augmentation extra-articular ligament | Augmentation of extra-articular ligament using autograft |
| Primary closure of congenital umbilical defect-all layers | N/A |
| Primary closure of congenital umbilical defect-skin only | Closure of congenital umbilical defect-skin only |
| Primary closure of congenital umbilical defect-with patch | Closure of congenital umbilical defect-with patch |
| Primary decompression of cervical spine | Decompression of cervical spine |
| Primary decompression of lumbar spine | Decompression of lumbar spine |
| Primary decompression of peripheral nerve | Decompression of peripheral nerve |
| Primary decompression of posterior fossa and upper cervical spinal cord and instrumentation | Decompression of posterior fossa and upper cervical spinal cord and instrumentation |
| Primary decompression of thoracic spine | Decompression of thoracic spine |
| Primary extended posterior decompression lumbar spine and fusion | Extended posterior decompression and fusion of lumbar spine |
| Primary extended posterior decompression of lumbar spine | Extended posterior decompression of lumbar spine |
| Primary extra-articular allograft augmentation intra-articular ligament | Extra-articular stabilization of joint using allograft |
| Primary extra-articular autograft augmentation intra-articular ligament | Extra-articular stabilization of joint using autograft |
| Primary extra-articular xenograft augmentation intra-articular ligament | Extra-articular stabilization of joint using xenograft |
| Primary foraminoplasty of cervical spine using laser | Foraminoplasty of cervical spine using laser |
| Primary foraminoplasty of lumbar spine using laser | Foraminoplasty of lumbar spine using laser |
| Primary foraminoplasty of spine | Foraminoplasty of spine |
| Primary foraminoplasty of thoracic spine using laser | Foraminoplasty of thoracic spine using laser |
| Primary foraminotomy of cervical spine | Foraminotomy of cervical spine |
| Primary foraminotomy of lumbar spine | Foraminotomy of lumbar spine |
| Primary hemilaminectomy for decompression of lumbar spine | Hemilaminectomy and decompression of lumbar spine |
| Primary intra-articular autograft augmentation intra-articular ligament | Augmentation of intra-articular ligament using intra-articular autograft |
| Primary optic nerve sheath meningioma | N/A |
| Primary posterior decompression cervical cord | Posterior decompression of cervical spinal cord |
| Primary posterior decompression cervical cord and fusion | Posterior decompression of cervical spinal cord and fusion |
| Primary posterior decompression lumbar spine | Posterior decompression of lumbar spinal cord |
| Primary posterior decompression of lumbar spinal cord | Posterior decompression of lumbar spinal cord |
| Primary posterior decompression of thoracic disc | Posterior decompression of thoracic disc |
| Primary prosthetic augmentation extra-articular ligament | Augmentation of extra-articular ligament using prosthetic ligament |
| Primary repair inguinal hernia using natural material | Repair of inguinal hernia using natural material |
| Primary repair of femoral hernia | Repair of femoral hernia |
| Primary repair of femoral hernia using insert of natural material | Femoral hernioplasty using natural material |
| Primary repair of femoral hernia using sutures | Repair of femoral hernia using surgical sutures |
| Primary repair of femoral hernia using synthetic patch | Repair of femoral hernia using synthetic patch |
| Primary repair of inguinal hernia | Repair of inguinal hernia |
| Primary repair of inguinal hernia and reduction of sliding hernia | Repair of inguinal hernia and reduction of sliding hernia |
| Primary repair of inguinal hernia using sutures | Inguinal herniorrhaphy |
| Primary repair of inguinal hernia using synthetic patch | Repair of inguinal hernia using synthetic patch |
| Primary repair of umbilical hernia | Repair of umbilical hernia |
| Primary repair of umbilical hernia using natural material | Repair of umbilical hernia using natural material |
| Primary repair of umbilical hernia using prosthetic material | Repair of umbilical hernia with prosthesis |
| Primary repair of umbilical hernia using suture | Repair of umbilical hernia using surgical sutures |
| Primary xenograft augmentation extra-articular ligament | Augmentation of extra-articular ligament using xenograft |
| Procedure by abdominal approach | N/A |
| Procedure by anterior approach | N/A |
| Procedure by colostomy approach | N/A |
| Procedure by extraoral approach | N/A |
| Procedure by intranasal approach | N/A |
| Procedure by intravesical approach | N/A |
| Procedure by perineal approach | N/A |
| Procedure by posterior approach | N/A |
| Procedure by sublabial approach | N/A |
| Procedure by suprapubic approach | N/A |
| Procedure by transanal approach | N/A |
| Procedure by transcervical approach – neck | N/A |
| Procedure by transcrotal approach | N/A |
| Procedure by transluminal approach | N/A |
| Procedure by transoral approach | N/A |
| Procedure by transsphenoidal approach | N/A |
| Procedure by transsternal approach | N/A |
| Procedure by transthoracic approach | N/A |
| Procedure by transurethral approach | N/A |
| Procedure by transvascular approach | N/A |
| Procedure by vaginal approach | N/A |
| Procedure recommendation categorized by action status | N/A |
| Procedure/intervention | N/A |
| Proctodynia | N/A |
| Proctogram | N/A |
| Proctomenia | Vicarious menstruation |
| Progesterone 416.667 microgram/hour prolonged-release vaginal ring | N/A |
| Progressive systemic sclerosis | N/A |
| Proprietary agent AND/OR biological product | N/A |
| Proprietary agent AND/OR biological substance | N/A |
| Proprietary cough compounds A-L | N/A |
| Proprietary cough compounds M-Z | N/A |
| Protein antigen | Antigen |
| Proteins A – R | N/A |
| Proteins S – Z | N/A |
| Protozoan parasite | N/A |
| Provision of community special services | N/A |
| Pseudomonas fulgida | Pseudomonas cedrina subspecies fulgida |
| Pseudomonas species a-f | N/A |
| Pseudomonas species g-r | N/A |
| Pseudomonas species s-z | N/A |
| Pseudomonas stanieri | Marinobacterium stanieri |
| Psoriasis and similar disorders | N/A |
| Psoriasis universalis | Erythrodermic psoriasis |
| Pulmonary structure including vessels and lymphoid tissue | N/A |
| Pulpotomy – vital – partial | N/A |
| Pygoamorphus | N/A |
| Quantitative measurement of cortisol in baseline serum or plasma specimen after ACTH challenge | Quantitative measurement of mass concentration of cortisol in baseline serum or plasma specimen after adrenocorticotropin challenge |
| Quantitative measurement of hydrocortisone in saliva specimen | Quantitative measurement of mass concentration of cortisol in saliva specimen |
| Quantitative measurement of mass concentration of hydrocortisone in p.m. serum or plasma | Quantitative measurement of mass concentration of cortisol in p.m. serum or plasma specimen |
| Quantitative measurement of mass concentration of hydrocortisone in serum or plasma obtained at a specified time | Quantitative measurement of mass concentration of cortisol in serum or plasma specimen obtained at a specified time |
| Quaternary ammonium derivative poisoning | N/A |
| Radiological reduction of intussusception of rectum using barium enema | Fluoroscopy guided reduction of intussusception of rectum with barium enema |
| Raised biochemistry finding | N/A |
| Raised hematology finding | N/A |
| Raised microbiology finding | N/A |
| Reactive laboratory finding | N/A |
| Reactive microbiology finding | N/A |
| Reading seizure | Epileptic seizures induced by reading |
| Rectal capsule – unit of product usage | Capsule |
| Rectal compounds+steroids A-Z | N/A |
| Rectal laxatives A-Z | N/A |
| Rectal stump blowout | N/A |
| Rectal tablet – unit of product usage | Tablet |
| Rectum double contrast examination | N/A |
| Regional back structure | N/A |
| Regional ileocolitis | N/A |
| Regional skeletal muscle structure | N/A |
| Removal of breast filler | N/A |
| Removal of product of conception of ectopic pregnancy | N/A |
| Removal of products of conception from fallopian tube | N/A |
| Renal function study | N/A |
| Renal sclerosis with hypertension | N/A |
| Respiratory technique education | N/A |
| Respiratory test categorized by action status | N/A |
| Respiratory tract and mouth | N/A |
| Respiratory virus Ag | N/A |
| Respiratory viruses | N/A |
| Response to immunization AND/OR skin test | N/A |
| Retrograde catheter ureteropyelography | Fluoroscopic retrograde ureteropyelography with contrast |
| Retrograde cystography | N/A |
| Retrograde ileoureterostogram | N/A |
| Retrograde pyelography of bilateral renal pelvises with contrast | Fluoroscopic retrograde pyelography of bilateral renal pelvises with contrast |
| Retrograde pyelography of left renal pelvis with contrast | Fluoroscopic retrograde pyelography of left renal pelvis with contrast |
| Retrograde pyelography of right renal pelvis with contrast | Fluoroscopic retrograde pyelography of right renal pelvis with contrast |
| Retroversion of uterus | Retroversion of uterus |
| Retroverted gravid uterus | Retroversion of gravid uterus |
| Revision allograft replacement extra-articular ligament | Extra-articular stabilization of joint using allograft |
| Revision extra-articular allograft augmentation intra-articular ligament | Extra-articular stabilization of joint using allograft |
| Revision extra-articular autograft augmentation intra-articular ligament | Extra-articular stabilization of joint using autograft |
| Revision extra-articular prosthetic augmentation intra-articular ligament | Extra-articular stabilization of joint using prosthetic ligament |
| Revision extra-articular xenograft augmentation intra-articular ligament | Extra-articular stabilization of joint using xenograft |
| Rhizomucor tauricus | Rhizomucor pusillus |
| Right metatarsus primus varus | N/A |
| Rivastigmine 192 microgram/hour prolonged-release transdermal patch | N/A |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch | N/A |
| Roseomonas fauriae | Azospirillum brasilense |
| Rotigotine 125 microgram/hour prolonged-release transdermal patch | N/A |
| Rotigotine 166.667 microgram/hour prolonged-release transdermal patch | N/A |
| Rotigotine 250 microgram/hour prolonged-release transdermal patch | N/A |
| Rotigotine 41.667 microgram/hour prolonged-release transdermal patch | N/A |
| Rotigotine 83.333 microgram/hour prolonged-release transdermal patch | N/A |
| Rubrobacteridae | N/A |
| Ruminococcus palsutris | Trichococcus palustris |
| Saccharomonospora paurometabolica | Saccharomonospora iraqiensis subsp. paurometabolica |
| Saccharomyces fragilis | Kluyveromyces marxianus |
| Sachet – unit of product usage | N/A |
| Salmonella group B phase 1 a-e | N/A |
| Salmonella group B phase 1 f-r | N/A |
| Salmonella group B phase 1 y-z | N/A |
| Salmonella group C1 and C4 phase 1 a-e | N/A |
| Salmonella group C1 and C4 phase 1 f-r | N/A |
| Salmonella group C1 and C4 phase 1 y-z | N/A |
| Salmonella group C2 and C3 phase 1 a-e | N/A |
| Salmonella group C2 and C3 phase 1 f-r | N/A |
| Salmonella group C2 and C3 phase 1 y-z | N/A |
| Salmonella group D1 phase 1 a-e | N/A |
| Salmonella group D1 phase 1 f-r | N/A |
| Salmonella group D1 phase 1 y-z | N/A |
| Salmonella group D2 phase 1 a-e | N/A |
| Salmonella group D2 phase 1 f-r | N/A |
| Salmonella group D2 phase 1 y-z | N/A |
| Salmonella group E1 phase 1 a-e | N/A |
| Salmonella group E1 phase 1 f-r | N/A |
| Salmonella group E1 phase 1 y-z | N/A |
| Salmonella group E4 phase 1 a-e | N/A |
| Salmonella group E4 phase 1 f-r | N/A |
| Salmonella group E4 phase 1 y-z | N/A |
| Salmonella group F phase 1 a-e | N/A |
| Salmonella group F phase 1 f-r | N/A |
| Salmonella group F phase 1 y-z | N/A |
| Salmonella group G1 and G2 phase 1 a-e | N/A |
| Salmonella group G1 and G2 phase 1 f-r | N/A |
| Salmonella group G1 and G2 phase 1 y-z | N/A |
| Salmonella group H phase 1 a-e | N/A |
| Salmonella group H phase 1 f-r | N/A |
| Salmonella group H phase 1 y-z | N/A |
| Salmonella group I phase 1 a-e | N/A |
| Salmonella group I phase 1 f-r | N/A |
| Salmonella group I phase 1 y-z | N/A |
| Salmonella group M phase 1 a-e | N/A |
| Salmonella group M phase 1 f-r | N/A |
| Salmonella group M phase 1 y-z | N/A |
| Salmonella group R phase 1 a-e | N/A |
| Salmonella group R phase 1 f-r | N/A |
| Salmonella group R phase 1 y-z | N/A |
| Saprozoonosis | N/A |
| Sawdust liver | N/A |
| Sclerosing mediastinitis | N/A |
| Sclerosing peritonitis as complication of peritoneal dialysis | N/A |
| Scopolamine 13.889 microgram/hour prolonged-release transdermal patch | N/A |
| Scopulariopsis cinerea | Microascus cinereus |
| Scriver-Goldbloom-Roy syndrome | N/A |
| Second degree | N/A |
| Secondary infected iridocyclitis | N/A |
| Secondary reading epilepsy | Epilepsy with reading-induced seizures |
| Secondary syphilis of viscera or bone | N/A |
| Secondary warm-type hemolytic anemia | N/A |
| Seizure co-occurrent and due to anxiolytic withdrawal | Acute symptomatic epileptic seizure due to anxiolytic withdrawal |
| Seizure co-occurrent and due to hypnotic withdrawal | Acute symptomatic epileptic seizure due to hypnotic withdrawal |
| Seizure co-occurrent and due to psychoactive substance withdrawal | Acute symptomatic epileptic seizure due to substance withdrawal |
| Seizure co-occurrent and due to sedative withdrawal | Acute symptomatic epileptic seizure due to sedative withdrawal |
| Seizure co-occurrent and due to substance withdrawal | Acute symptomatic epileptic seizure due to substance withdrawal |
| Seizure disorder as sequela of stroke | Acute symptomatic epileptic seizure due to cerebrovascular accident |
| Seizure due to migraine with aura | N/A |
| Seizures complicating infection | Acute symptomatic epileptic seizure due to acute infectious disease |
| Seizures complicating intracranial hemorrhage | Acute symptomatic epileptic seizure due to intracranial hemorrhage |
| Seizures complicating intracranial hemorrhage in the newborn | Acute symptomatic epileptic seizure due to perinatal intraventricular hemorrhage |
| Seizures due to metabolic disorder | Acute symptomatic epileptic seizure due to metabolic disorder |
| Selegiline 250 microgram/hour prolonged-release transdermal patch | N/A |
| Selegiline 375 microgram/hour prolonged-release transdermal patch | N/A |
| Selegiline 500 microgram/hour prolonged-release transdermal patch | N/A |
| Selenomonas acidaminovorans | Thermanaerovibrio acidaminovorans |
| Self hanging, strangulation or suffocation | N/A |
| Senile cardiac amyloidosis | N/A |
| Setosphaeria rostrata | Exserohilum rostratum |
| Sex chromosome | N/A |
| Sex pilum | N/A |
| Shewanella geldimarina | Shewanella gelidimarina |
| Shigella flexneri 5a [V:3,4] | N/A |
| Shigella flexneri 5b [V:7,8] | N/A |
| Short stature of childhood | N/A |
| Sibbens | N/A |
| Sickle cell disease screening test | N/A |
| Sickness in family | N/A |
| Silicibacter | Ruegeria |
| Single contrast barium enema | N/A |
| Single contrast barium meal | Fluoroscopy of upper gastrointestinal tract with barium contrast |
| Single contrast barium swallow | Fluoroscopy of upper gastrointestinal tract with barium contrast |
| Site of (a-h) | N/A |
| Site of (i-z) | N/A |
| Situation-related seizures | Acute symptomatic epileptic seizure |
| Skin and subcutaneous tissue complication following insertion of filling material under skin | Skin and/or subcutaneous tissue complication following insertion of soft tissue filling material under skin |
| Skull and/or spine and/or bone and/or joint operations | N/A |
| Small bowel meal | N/A |
| Small bowel meal plus pneumocolon | Fluoroscopic barium meal and follow through with pneumocolon |
| Small bowel series | N/A |
| Small bowel series with water soluble contrast follow through | Fluoroscopic water soluble contrast meal and follow through |
| Smoker’s respiratory syndrome | Disorder of respiratory system |
| Smoking AND/OR drinking habits | N/A |
| Smooth endoplasmic reticulum | N/A |
| Sodium rhodanide | N/A |
| Soft tissue | N/A |
| Solid barium swallow | Fluoroscopy of upper gastrointestinal tract with barium contrast coated solid food swallow |
| Solvent A – C | N/A |
| Solvent D – F | N/A |
| Solvent H – I | N/A |
| Solvent M – O | N/A |
| Solvent P | N/A |
| Solvent S – Z | N/A |
| Somantin | N/A |
| Special female test done | N/A |
| Special male test done | N/A |
| Special peripheral angiography procedures | Peripheral angiography |
| Specific drug AND/OR toxicology test | N/A |
| Specimen related microbial interpretation | N/A |
| Sphaerobacteridae | N/A |
| Sphingobacterium yabuuchiae | N/A |
| Sphingomonas cloacae | Sphingobium cloacae |
| Spinal decompression without discectomy | Decompression of spine |
| Sponge – unit of product usage | N/A |
| Sporotrichum beurmanni | Sporothrix schenkii |
| Squash | N/A |
| Squill opiate | N/A |
| Stachybotrys alternans | Stachybotrys chartarum |
| Staphylococcus petrasii subspecies jettensis | Staphylococcus petrasii |
| Staphylococcus petrasii subspecies petrasii | Staphylococcus petrasii |
| Staphylococcus schleiferi subsp. coagulans | Staphylococcus coagulans |
| Startle partial seizure | Epileptic seizures induced by startle |
| Stick – unit of product usage | N/A |
| Stoma belt | N/A |
| Strain of long head of biceps | N/A |
| Strained hoarse voice arrest-intermittent arrhythmic group | Hoarse |
| Strained hoarse voice arrest-intermittent rhythmic group | Hoarse |
| Strained hoarse voice-continuous group | Hoarse |
| Streptococcus oligofermentans | Streptococcus cristatus |
| Streptomyces albovinaceus | Streptomyces globisporus |
| Streptomyces alboviridis | Streptomyces microflavus |
| Streptomyces almquistii | Streptomyces albus |
| Streptomyces bambergiensis | Streptomyces prasinus |
| Streptomyces cavourensis subspecies washingtonensis | Streptomyces cyaneofuscatus |
| Streptomyces cyanoalbus | Streptomyces hirsutus |
| Streptomyces diastaticus ardesiacus | Streptomyces ardesiacus |
| Streptomyces diastaticus diastaticus | Streptomyces diastaticus |
| Streptomyces endus | Streptomyces hygroscopicus |
| Streptomyces floridae | Streptomyces californicus |
| Streptomyces fluorescens | Streptomyces anulatus |
| Streptomyces melanogenes | Streptomyces noboritoensis |
| Streptomyces phaeopurpureus | Streptomyces griseorubiginosus |
| Streptomyces rangoonensis | Streptomyces albus |
| Streptomyces rutgersensis | Streptomyces diastaticus |
| Streptomyces rutgersensis castelarensis | Streptomyces castelarensis |
| Streptomyces rutgersensis rutgersensis | Streptomyces diastaticus |
| Streptomyces sporocinereus | Streptomyces hygroscopicus |
| Streptosporangium claviforme | Herbidospora cretacea |
| Stress cystogram | N/A |
| Stress-induced epilepsy | Epilepsy |
| Strip – unit of product usage | N/A |
| Stroke / transient ischemic attack referral | N/A |
| Stropharia cubensis | Psilocybe cubensis |
| Structure of breast and/or endocrine system | N/A |
| Structure of Fleischmann’s bursa | N/A |
| Structure of granulosum of ovarian follicle | N/A |
| Structure of physiologic cup of optic disc | Structure of optic cup |
| Structure of product of conception of ectopic pregnancy | N/A |
| Structure of respiratory system and/or intrathoracic structure | N/A |
| Structure of throat | Structure of pharynx and/or larynx |
| Subarterial ventricular septal defect | N/A |
| Subclass Acidimicrobidae | N/A |
| Subcutaneous administration of treatment | N/A |
| Subcutaneous injection of filling material | Subcutaneous injection of soft tissue filling material |
| Sublingual administration of treatment | N/A |
| Sublingual tablet – unit of product usage | Tablet |
| Subsidiary classification of laterality and operation sites | N/A |
| Substances, materials and objects | N/A |
| Suicide and self inflicted injury by amylobarbital | N/A |
| Suicide and self inflicted injury by Barbitone | N/A |
| Suicide and self inflicted injury by barbiturates | N/A |
| Suicide and self inflicted injury by Butabarbitone | N/A |
| Suicide and self inflicted injury by Pentabarbitone | N/A |
| Suicide and self inflicted injury by phenobarbital | N/A |
| Suicide and self inflicted injury by Quinalbarbitone | N/A |
| Suicide and self inflicted poisoning by barbiturates | N/A |
| Suicide and selfinflicted injury | N/A |
| Suicide and selfinflicted injury by caustic substances, excluding poisoning | N/A |
| Suicide and selfinflicted injury by drowning | N/A |
| Suicide and selfinflicted injury by hanging, strangulation and suffocation | N/A |
| Suicide and selfinflicted injury by jumping before moving object | N/A |
| Suicide and selfinflicted injury by jumping from natural sites | N/A |
| Suicide and selfinflicted injury by jumping from residential premises | N/A |
| Suicide and selfinflicted injury by jumping or lying before moving object | N/A |
| Suicide and selfinflicted injury by lying before moving object | N/A |
| Suicide and selfinflicted injury by suffocation by plastic bag | N/A |
| Suicide and selfinflicted poisoning by analgesics, antipyretics and anti-rheumatics | N/A |
| Suicide and selfinflicted poisoning by solid and liquid substances | N/A |
| Suicide or attempted suicide by drowning | N/A |
| Suicide or attempted suicide by hanging | N/A |
| Suicide or self injury associated with moving vehicles | N/A |
| Suicide or self injury by arson | N/A |
| Suicide or self injury by burning or fire | N/A |
| Suicide or self injury by electric current | N/A |
| Suicide or self injury by exposure to cold | N/A |
| Suicide or self injury by igniting gasoline soaked clothing | N/A |
| Suicide or self injury by jumping from a height | N/A |
| Suicide or self injury by jumping from bridge | N/A |
| Suicide or self injury by jumping from high building | N/A |
| Suicide or self injury by jumping from high man-made structure | N/A |
| Suicide or self injury by jumping from high natural feature | N/A |
| Suicide or self injury by jumping off cliff | N/A |
| Suicide or self injury by placing self in path of moving motor vehicle | N/A |
| Suicide or self injury by placing self in path of moving railway vehicle | N/A |
| Suicide or self injury by placing self in path of moving vehicle | N/A |
| Suicide or self injury by scalding | N/A |
| Suicide or selfinflicted injury by crashing motor vehicle | N/A |
| Suicide or selfinflicted injury by crashing of aircraft | N/A |
| Suicide or selfinflicted injury by cutting | N/A |
| Suicide or selfinflicted injury by cutting and stabbing | N/A |
| Suicide or selfinflicted injury by explosives | N/A |
| Suicide or selfinflicted injury by firearms and explosives | N/A |
| Suicide or selfinflicted injury by handgun | N/A |
| Suicide or selfinflicted injury by hunting rifle | N/A |
| Suicide or selfinflicted injury by military firearm | N/A |
| Suicide or selfinflicted injury by shotgun | N/A |
| Suicide or selfinflicted injury by stabbing | N/A |
| Sunscreening preparations A-Z | N/A |
| Supplementary and complete feeds A to F | N/A |
| Supplementary and complete feeds F to P | N/A |
| Supplementary and complete feeds N to Z | N/A |
| Suppository – unit of product usage | N/A |
| Suppurative lymphadenopathy | N/A |
| Supracristal ventricular septal defect | N/A |
| Surgical iridectomy | N/A |
| Surgical peripheral iridectomy | N/A |
| Swab – unit of product usage | N/A |
| Swallowed whole | N/A |
| Sycosis cruris | N/A |
| Synovial fluid fibrin clot | N/A |
| Tablet – unit of product usage | N/A |
| Tampon | N/A |
| Tapetoretinal dystrophy | Retinitis pigmentosa |
| Team meeting | N/A |
| Technetium (99-Tc) lidofenin | N/A |
| Techniques A-L | N/A |
| Techniques M-Z | N/A |
| Template entry – EHR category | N/A |
| Tenosynovitis of fingers | Tenosynovitis of finger |
| Tentorial laceration – acute syndrome | N/A |
| Tentorial laceration – subacute syndrome | N/A |
| Test control | Diagnostic substance |
| Test finding | N/A |
| Testosterone 104.167 microgram/hour prolonged-release transdermal patch | N/A |
| Testosterone 208.333 microgram/hour prolonged-release transdermal patch | N/A |
| Testosterone 250 microgram/hour prolonged-release transdermal patch | N/A |
| Therapeutic barium enema | N/A |
| Therapeutic barium enema for reduction of intussusception | Reduction of intestinal intussusception with barium enema using fluoroscopic guidance |
| Therapeutic water soluble enema and fluoroscopy of colon | Fluoroscopy of lower gastrointestinal tract with water soluble contrast enema |
| Thermoactinomyces dichotomicus | Thermoflavimicrobium dichotomicum |
| Thermoactinomyces peptonophilus | Seinonella peptonophila |
| Thermoactinomyces putidus | Laceyella putida |
| Thermomonospora alba | Thermobifida alba |
| Thermomonospora fusca | Thermobifida fusca |
| Thermomonospora mesophilia | Sphaerimonospora mesophila |
| Thermomonospora mesouviformis | Thermobifida alba |
| Thermotherapy | N/A |
| Thermotherapy with hot packs | N/A |
| Thiocyanate compound | Thiocyanate |
| Third degree | N/A |
| Thomas’ sign | N/A |
| Thoracodidymus | N/A |
| Thoracoparacephalus | N/A |
| Thrombotic disorder | N/A |
| Thymic ectopic endocrine substance | Ectopic thymus secretion |
| Thymic erythropoietin suppression factor | N/A |
| Thymic lymphopoietin suppressing factor | N/A |
| Thymidine (18-F) | N/A |
| Tick-borne bunyavirus hemorrhagic fever | N/A |
| Tick-borne coltivirus encephalitis | N/A |
| Tick-borne encephalitis | N/A |
| Tick-borne flavivirus hemorrhagic fever | N/A |
| Tick-borne hemorrhagic fever | N/A |
| Tick-borne orbivirus encephalitis | N/A |
| Tick-borne orbivirus fever | N/A |
| Tick-borne orthobunyavirus fever | N/A |
| Tick-borne rickettsiosis | N/A |
| Tinea capitis caused by Microsporum canis variant distortum | Tinea capitis caused by Microsporum equinum |
| Tinea capitis caused by Trichophyton megninii | Tinea capitis caused by Trichophyton rubrum |
| Tinea caused by Microsporum canis variant distortum | Tinea caused by Microsporum equinum |
| Tinea caused by Trichophyton equinum | Tinea caused by Trichophyton tonsurans |
| Tinea caused by Trichophyton megninii | Tinea caused by Trichophyton rubrum |
| Tinea corporis caused by Microsporum distortum | Tinea corporis caused by Microsporum equinum |
| Tinea corporis caused by Trichophyton megninii | Tinea corporis caused by Trichophyton rubrum |
| Tissue ameba | N/A |
| Tissue fluke | N/A |
| Tissue impression smear specimen | N/A |
| Tissue nematode | N/A |
| ton | N/A |
| Topical administration of treatment | N/A |
| Touch preparation cytologic material | Tissue impression specimen |
| Toxic effect of benzene AND/OR homologue | N/A |
| Toxic effect of chemical | N/A |
| Toxic effect of chiefly nonmedicinal substance | N/A |
| Toxic effect of nonpetroleum-based solvent | N/A |
| Toxic effect of organophosphate AND/OR carbamate pesticide | N/A |
| Toxic plant | Plants |
| Tracheal lymphadenopathy | N/A |
| Transcatheter therapy by infusion with angiography | N/A |
| Transdermal administration of treatment | N/A |
| Transfusion and related procedures | N/A |
| Transient neonatal hematological disorder | N/A |
| Transurethral radiofrequency thermotherapy | N/A |
| Transverse deficiency of arm, upper arm level – long | N/A |
| Transverse deficiency of arm, upper arm level – short | N/A |
| Traumatic anterior urethral stricture | N/A |
| Traumatic brain injury with no loss of consciousness | N/A |
| Traumatic bulbous urethral stricture | N/A |
| Traumatic membranous urethral stricture | N/A |
| Traumatic neonatal facial cyanosis | N/A |
| Traumatic stricture of female urethra | N/A |
| Traumatic urethral stricture | N/A |
| Treatment administration via gastrostomy | N/A |
| Treatment via bladder catheter | N/A |
| Trichophobia | N/A |
| Trichophyton equinum | Trichophyton tonsurans |
| Trichophyton equinum var equinum | Trichophyton tonsurans |
| Trichophyton equinum var. autotrophicum | Trichophyton tonsurans |
| Trichophyton fischeri | Trichophyton rubrum |
| Trichophyton kanei | Trichophyton rubrum |
| Trichophyton megninii | Trichophyton rubrum |
| Trichophyton mentagrophytes (var. granulare) | N/A |
| Trichophyton raubitschekii | Trichophyton rubrum |
| Tritirachium roseum | Tritirachium oryzae |
| Tube – unit of product usage | N/A |
| Tube esophagram | Fluoroscopy of esophagus with contrast via nasogastric tube |
| Tuberculosis of hip | N/A |
| Tuberculosis of middle ear | N/A |
| Tuberculous bronchiectasis | N/A |
| Tuberculous tenosynovitis | N/A |
| Tumor location cannot be determined | N/A |
| Tumor of dermis | N/A |
| Tumor of lymphoid, hemopoietic and related tissue | N/A |
| Tumor of mesothelial and soft tissue | N/A |
| Tumor-like lesion of brain | N/A |
| Tumor-like lesion of esophagus | N/A |
| Tumor-like lesion of esophagus, stomach and duodenum | N/A |
| Tumor-like lesion of intestine | N/A |
| Tumor-like lesion of nervous system | N/A |
| Tumor-like lesion of skin | N/A |
| Turacoporphyrin | N/A |
| Type attribute A – C | N/A |
| Type attribute D – F | N/A |
| Type attribute G – L | N/A |
| Type attribute M – P | N/A |
| Type attribute R – S | N/A |
| Type attribute T – Z | N/A |
| Types of drugs A-G | N/A |
| Types of drugs H-M | N/A |
| Types of drugs N-S | N/A |
| Types of drugs T-Z | N/A |
| Ulcerated varices | N/A |
| Ulocladium chartarum | Alternaria chartarum |
| Unable to transfer between wheelchair and toilet | N/A |
| Unreliable laboratory result | N/A |
| Upper gastrointestinal tract contrast procedure | Imaging of upper gastrointestinal tract with contrast |
| Upper gastrointestinal tract series | N/A |
| Upper respiratory fluids and spaces | N/A |
| Uremic convulsion | Acute symptomatic epileptic seizure due to uremia |
| Ureterogram | N/A |
| Urethral administration of treatment | N/A |
| Urinary crystal, magnesium ammonium phosphate | N/A |
| Urogenital protozoan | N/A |
| Urovagina | N/A |
| Ustilago zeae | Ustilago maydis |
| Uterine incoordination, first degree | Dyscoordinate labor |
| Uterine incoordination, second degree | Dyscoordinate labor |
| Vaccine and biological substance | N/A |
| VACTEL syndrome | N/A |
| Vaginal capsule – unit of product usage | Capsule |
| Vaginal suppository – unit of product usage | N/A |
| Vaginal tablet – unit of product usage | Tablet |
| Valinosis | N/A |
| Vector-transmitted infectious disease | N/A |
| Veillonella parvula ss atypica | Veillonella atypica |
| Veillonella parvula ss parvula | Veillonella parvula |
| Veillonella parvula ss rodentium | Veillonella rodentium |
| Very preterm maturity of infant | N/A |
| Vial – unit of product usage | N/A |
| Vibrio panaeicida | Vibrio penaeicida |
| Vibrio species a-m | N/A |
| Vibrio species n-z | N/A |
| Vibrio splindidus | Vibrio splendidus |
| Video soft palate | N/A |
| Videoswallow | Videofluoroscopy swallow |
| Villous arthritis | Chronic synovitis |
| Viral encephalitis transmitted by tick | N/A |
| Visit with nurse at next appointment requested | Visit with nurse at next appointment requested |
| Visual test categorized by action status | N/A |
| Vitellibacter | Aequorivita |
| Voice cluster | Voice finding |
| Voice tremor group | Voice tremor |
| Wafer – unit of product usage | N/A |
| Water soluble contrast enema | Fluoroscopy of lower gastrointestinal tract with water soluble contrast enema |
| Water soluble contrast meal | Fluoroscopy of gastrointestinal tract using water soluble contrast swallow and meal |
| Water soluble contrast swallow | N/A |
| Wet dreams | N/A |
| Whiplash shaken infant syndrome | Shaken baby syndrome |
| Whirling disease | N/A |
| Zooanthroponosis | N/A |
| Zoonosis | N/A |
| Zoonotic bacteria | N/A |
| Zoonotic bacterial disease | N/A |
| Zoonotic pathogen | N/A |
| Zooparasitic portal cirrhosis | N/A |
| Zymophilus | Propionispira |
